Emrelis Prices, Discounts & Coupons

Used for Cancer

NowPatient can significantly lower the cost* of your prescription medication by providing free access to drug coupons, savings cards, patient assistance programs and other out of pocket discount programs. Whether you’re insured, uninsured, or underinsured, we empower you with transparency and cost-saving tools to make your Emrelis more affordable.

Manufactured by UCB Inc.
*You can pay as little as $0 per fill using Drug Coupons or Patient Assistance Programs. Subject to applicability & eligibility requirements.

Start Saving Today!

Lower the Cost of Your Emrelis Prescription

You can lower the cost of your Emrelis Rx by using one of the 4 drug savings programs below
  • NowPatient's Rx Advantage card is a simple & convenient way to save money on your EMRELIS

    Rx Advantage Card

    Our savings card can be used in over 65,000 pharmacies and could save you up to 90% on the cost of your medication. Suitable for insured, underinsured and uninsured individuals. This is not health insurance and cannot be used in conjunction with insurance.

  • Unavailable
    N/A
    Manufactured by
    N/A
    Powered by
    Buy your EMRELIS without insurance from Canada at discounts of up to 90% using NowPatient's Canadian Prescription savings program.

    Canadian Online Pharmacy

    Our trusted licensed Canadian pharmacy partner, Prescription Help, is on hand to offer great savings on the cost of your medications.

    Unavailable
  • Unavailable
    Obtain your EMRELIS for as little as $0 per fill. Suitable for insured individuals only.

    Drug Coupons

    For those who are commercially insured, drug manufacturer coupons can help reduce your out-of-pocket costs. Eligible for commercially insured only.

    Unavailable
  • Unavailable
    Obtain your EMRELIS at no cost. Suitable for insured, underinsured and uninsured individuals

    Patient Assistance Programs

    Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and can mean you can obtain your medications at no cost to you. Suitable for insured, underinsured and uninsured individuals who are financially constrained.

    Unavailable

MEDICAL INFORMATION

Emrelis Key Facts

What is Emrelis?

Emrelis is the brand name for telisotuzumab vedotin-tllv and is available as an intravenous infusion.

What dosages is Emrelis available in?

Emrelis is available as a single-dose vial containing 20 mg or 100 mg of telisotuzumab vedotin-tllv.

What is Emrelis used for?

Emrelis is used in the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC).

How does Emrelis work?

Emrelis is a c-Met-directed antibody and microtubule inhibitor conjugate. Thiis combination of a targeted antibody with a potent chemotherapy agent helps kill cancer cells while minimizing harm to healthy tissue.

How do I take Emrelis?

The recommended dosage of Emrelis is 1.9 mg/kg administered intravenously every 2 weeks until disease progression or unacceptable toxicity.

Is it safe for me to take Emrelis?

Emrelis is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

Emrelis Common Side Effects

Common side effects of Emrelis:

  • Peripheral neuropathy
  • Fatigue
  • Decreased appetite
  • Peripheral edema

Emrelis Serious Side Effects

Serious side effects are rare with . Contact your healthcare provider immediately if you experience any of the following:

  • Lung problems: new or worsening cough, trouble breathing, fever, or wheezing
  • Eye problems: blurred vision, dry eyes, light sensitivity, pain, swelling, or redness.
  • Infusion-related reactions: itching, rash, shortness of breath, wheezing, flushing, chest discomfort, fever, back pain, chills, headache, nausea, vomiting, and lightheadedness

Effects of other drugs, drug classes and over-the-counter products on Emrelis

The following medications may interact with Emrelis:

  • Strong CYP3A Inhibitors

Who makes Emrelis?

UCB Inc.

Is Emrelis safe in pregnancy?

Based on the mechanism of action and findings in animals, Emrelis can cause fetal harm when administered to a pregnant woman. Talk to your doctor if you are already pregnant or if you have plans on becoming pregnant. They will recommend what is best for you.

What is the generic name for Emrelis?

Drug Savings Guide

A Practical Guide to Saving Money and Receiving Support With Prescription Drug Costs

How can NowPatient help me to lower the cost of my Emrelis prescription?

After you create a FREE account with NowPatient, you will have access to 4 programs that can help lower the cost of your Emrelis prescription

Applicability to each program will be dependent on your insurance status.

How do the NowPatient Emrelis savings programs work?

After you have created your FREE account with NowPatient, you can access the various programs from your account dashboard. Each program has clear instructions on how to check your eligibility. You can see how the process works by clicking on the feature link below and seeing the ‘How it works’ steps.

Drug Coupon and Patient Assistance Programs require an eligibility quiz to be completed.

Are the NowPatient Emrelis savings programs suitable for everyone, regardless of insurance status?

No. Each program has its own eligibility and applicability requirements. The table below shows if a program is available to you, based on your insurance status.

Rx Advantage Card* for EmrelisCanadian Prescription Savings* for EmrelisEmrelis Drug Coupon*Emrelis Patient Assistance Program*
Insured (federal, state or government)AvailableAvailableNot AvailableAvailable If Offered by Pharmaceutical Company
Insured (Commercial or Private)AvailableAvailableAvailable If Offered by Pharmaceutical CompanyAvailable If Offered by Pharmaceutical Company
UninsuredAvailableAvailableNot AvailableAvailable If Offered by Pharmaceutical Company
Insured but without pharmacy benefit or drug coverageAvailableAvailableNot AvailableAvailable If Offered by Pharmaceutical Company

*This is not insurance.

Are the NowPatient drug savings programs suitable for brand and generic versions of Emrelis?

No. Each program has applicability requirements. Please see below

Rx Advantage Card* for EmrelisCanadian Prescription Savings* for EmrelisEmrelis Drug Coupon*Emrelis Patient Assistance Program*
BrandYesYesYes, If Offered by Pharmaceutical CompanyYes, If Offered by Pharmaceutical Company
GenericYesYesNoNo

*This is not insurance.

If you have Medicare Part D or Medicare Advantage and none of the Emrelis savings options are applicable or affordable for me, what can you do?

If you are insured with Medicare and the Emrelis drug savings options are not applicable to you and still remain unaffordable, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.

The government site is easy to use and after you have selected your state, it will navigate you to the appropriate contact point to make the application. State Medicaid programs may cover the full cost of your medication.

People who qualify for both Medicare and Medicaid are called ‘dual eligibles’.

If you are denied Medicaid for Emrelis, and you are still unable to afford your copay or co-insurance element (for example if you are in the coverage gap or Donut Hole) then you may be eligible for a federal support program like Low Income Subsidy. To be eligible for Low Income Subsidy, you need to be a resident in one of the 50 States or the District of Columbia. You can check eligibility online at SSA Medicare D Extra Help. You can also call Social Security at 1-800-772-1213 (TTY 1-800-325-0778).

I am uninsured or underinsured and none of the Emrelis prescription saving options are applicable or affordable for me, what can I do?

If you are uninsured or underinsured (for example, Emrelis is not covered by your plan) and the drug savings options are not applicable or still unaffordable, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.

The government site is easy to use and you can select your state and it will navigate you to the appropriate contact point to make the application. State Medicaid programs may cover the full cost of your medication.

If you are denied and all else fails, and if you have been prescribed Emrelis for an FDA-approved indication, you can call the pharmaceutical company to see if they have any other assistance programs.

I am commercially or privately insured and none of the Emrelis prescription saving options are applicable or affordable for me, what can I do?

If your medication is not covered by your plan, you can you can appeal your insurance company’s decision. Sometimes, a formal appeal can result in the drug being covered if it is deemed medically necessary.

If you cannot afford your copay, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.

However, being privately insured might complicate your eligibility for Medicaid, as having private insurance may be considered in the financial eligibility assessment.

The government site is easy to use and you can select your state and it will navigate you to the appropriate contact point to make the application. If you qualify, state Medicaid may cover the full cost of your medication.

If I have federal, state or commercial insurance and none of the Emrelis prescription saving options are applicable or affordable for me, are there any other support organisations that can help me with my co-insurance or copay?

If you have already tried Medicaid and received a denial letter or if you are insured with Medicare and have been denied Low-Income Subsidy, then you can try one of the following organizational support programs:

1. Patient Access Network Foundation (PAN) assistance for Emrelis

If you are having trouble paying for your Emrelis medication due to unaffordable copays or deductibles, the Patient Access Network Foundation (PAN), may be able to assist you. To qualify for PAN assistance for Emrelis you will need to meet one or all of the following criteria:

  • Your income is below 400% of the federal poverty level
  • Emrelis is prescribed for an approved FDA indication
  • You live in and receive treatment in the United States or U.S. territories, even if you do not have U.S. citizenship
  • You have Medicare insurance coverage that covers Emrelis
  • If Emrelis is listed on PAN’s list of covered medications

You can check the Patient Access Network Foundation Website for more information.

2. HealthWell Foundation Copay Program for Emrelis

If you are having trouble paying for your Emrelis medication due to unaffordable copays or deductibles, the HealthWell Foundation Copay Program may be able to assist you. To qualify for assistance for Emrelis you will need to meet the following criteria:

  • You live in and are being treated in the United States
  • You are insured and your plan covers Emrelis
  • If Emrelis is listed on the HealthWell Foundation’s list of covered medications

You can check the HealthWell Foundation Website for more information.

3. Patient Advocate Foundation Co-Pay Relief Program for Emrelis

Patient Advocate Foundation’s Co-Pay Relief program exists to help reduce the financial distress you or your family may face when paying for your Emrelis treatment. If you qualify and can demonstrate the need, the foundation will provide you with direct payment covering co-pays, co-insurance, and deductibles. To qualify for assistance for Emrelis you will need to meet the following criteria:

  • You must be currently insured and have coverage for Emrelis
  • You must have a confirmed diagnosis and treatment plan
  • You must reside and receive treatment in the United States
  • Your Income must fall at or below 300% or 400% of the Federal Poverty Guideline (FPG) with consideration for the Cost of Living Index (COLI) and number in the household
  • Applications can also be completed by contacting the program sponsor, toll-free at 866-512-3861.

You can check the Patient Advocate Foundation Website for more information.

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

HELPING MAKE MEDICINES SAFER

Report Side Effects to UK MHRA Yellow Card or US FDA MedWatch

Yellowcard logo
Medwatch logo
Now Patient SideEffects